RxDoctor Payments Data

Marina Gozha

Physician Assistant · Virginia Beach, VANPI 1952904872

Payments from drug & device makers

$4,508in general payments, 2019–2025

Across 227 payments — averaging $19.86 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Johnson & Johnson$1K
  • AbbVie$763
  • E.r. Squibb & Sons, L.L.C.$421
  • Supernus Pharmaceuticals, Inc.$363
  • Alkermes, Inc.$330
  • Neurocrine Biosciences, Inc.$231
  • plus $1K from 15 others

What the payments were for

  • Food & beverage$4,508100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$4,508 in reported general payments places this provider in the 90th percentile of 3,376 physician assistant providers in Virginia.

See all physician assistant providers in Virginia

Medicare billing

Part B allowed, 2024
$34,572
Medicare patients
89
Services billed
453

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
VyvanseLisdexamfetamine Dimesylate22$8,258
Aripiprazole118$3,545
Imipramine Pamoate14$3,298
Divalproex Sodium ErDivalproex Sodium46$1,929
Methylphenidate ErMethylphenidate Hcl35$1,553
Dextroamphetamine-Amphet ErDextroamphetamine/Amphetamine52$1,386
Bupropion XlBupropion Hcl95$993
Olanzapine57$928
Trazodone Hcl146$904
Risperidone50$896
Quetiapine Fumarate94$802
Divalproex Sodium28$798
Haloperidol11$750
Sertraline Hcl99$695
Oxcarbazepine40$625

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Takeda Pharmaceuticals U.S.A., Inc.Vyvanse$187$8,25822 claims
Almatica Pharma LLCSertraline Hcl$37$69599 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 3,376 physician assistant providers in Virginia.

Other physician assistant in Virginia Beach

See the full list for Virginia

Where these figures come from

Is this you, or does something look wrong? →